Literature DB >> 33384518

Cardiac Intensive Care Unit Admissions during COVID-19 Pandemic-A Single Center Experience.

Radhapriya Yalamanchi1, Bipin Chandra Dasari1, Lavanya Narra1, Abraham Oomman1, Pramod Kumar1, Rajeshwari Nayak1, Refai Showkathali1.   

Abstract

AIM: The impact of coronavirus disease 2019 (COVID-19) lockdown on cardiac emergency admissions to hospitals has been reported previously. We aimed to study the emergency room (ER) admissions to cardiac intensive care unit (CICU) at a tertiary care center during that period and compare this with admissions during the same time frame in the previous years.
MATERIALS AND METHODS: This is a retrospective observational study of patients admitted to the CICU during the pandemic period from March 22 to August 1 (inclusive) of 2020 and compared this with CICU admissions in the same time frame in the previous 2 years (2018 and 2019).
RESULTS: During the study period in 2020, a total of 216 patients (age 59 ± 14 years) were admitted via ER, which is a 33% and 30% decline in admissions compared to 2019 (n = 322, age 63 ± 12 years) and 2018 (n = 307, age 62 ± 13), respectively. The decline in admissions with the primary diagnosis of acute coronary syndrome (ACS), acute decompensated heart failure, arrhythmia, and other diagnoses during the study period in 2020 were 27%, 38%, 62%, and 59%, respectively, while there was a 50% increase in acute pulmonary embolism admission compared to the mean admission in 2018 and 2019. Weekly admission rates gradually increased from less than 10 per week in the first 3 weeks to >15 by eighth week of the study period in 2020, while the trend was same throughout the study period in the previous 2 years. The CICU mortality rate in 2020 study period was 4.6% compared to 3.9% in 2018 (p = 0.83) and 5.6% in 2019 (p = 0.70). The in-hospital mortality of these patients was also similar in all 3 years (6.5%, 7.8%, and 7.9% in 2018, 2019, and 2020, respectively; p = 0.61).
CONCLUSION: Our study showed that CICU admissions during COVID-19 lockdown had declined compared to the previous years in a large tertiary center in India. Government and health organizations should educate the public early on during the pandemic about the consequences of ignoring other acute medical problems such as ACS, provide various measures for them to reach hospital early, and give reassurance with the best practices adopted in hospitals to avoid contracting the virus from the hospital environment. HOW TO CITE THIS ARTICLE: Yalamanchi R, Dasari BC, Narra L, Oomman A, Kumar P, Nayak R, et al. Cardiac Intensive Care Unit Admissions during COVID-19 Pandemic-A Single Center Experience. Indian J Crit Care Med 2020;24(11):1103-1105.
Copyright © 2020; Jaypee Brothers Medical Publishers (P) Ltd.

Entities:  

Keywords:  Acute coronary syndrome; Acute decompensated heart failure; Admissions; COVID-19; Cardiac emergency; Cardiac intensive care unit; Lockdown; Pandemic; Pulmonary embolism

Year:  2020        PMID: 33384518      PMCID: PMC7751044          DOI: 10.5005/jp-journals-10071-23660

Source DB:  PubMed          Journal:  Indian J Crit Care Med        ISSN: 0972-5229


Introduction

Coronavirus disease 2019 (COVID-19) was declared as a pandemic by the World Health Organization on March 11, 2020.[1] Further to this, most countries around the world imposed strict lockdown measures to contain the transmission of the virus at different time frames. The Indian government announced the first lockdown starting from March 24 for a period of 21 days, which subsequently got extended to different time frames in different states. Cardiovascular involvement of COVID-19 can range from acute coronary syndrome (ACS), acute myocardial injury without obstructive coronary artery disease (myocarditis, stress cardiomyopathy), arrhythmias, heart failure, cardiogenic shock, pericardial effusion, and various thromboembolic complications.[2] Cardiac societies such as the American College of Cardiology and Cardiological Society of India released guidelines about the management of patients with cardiovascular disease and myocardial infarction during COVID-19 in April 2020. These guidelines addressed the concerns about the safety of healthcare workers without compromising the best delivery of care to the patient.[3,4] Reports of several studies from various countries were published showing significant reduction in admission of patients with cardiac emergency to hospital during this period of lockdown.[5-14] We aimed to study the emergency room (ER) admissions to cardiac intensive care unit (CICU) at a tertiary care center during this period of lockdown and compared with admissions during the same period in the previous years.

Materials and Methods

This is a retrospective observational study of patients getting admitted to the CICU during the COVID-19 pandemic period from March 22 to August 1 (inclusive) of 2020 to our institute. Information about the CICU admissions during the same period of the previous 2 years (2018 and 2019) were also collected. The data were obtained from our electronic database and medical records of patients. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. We analyzed the patient records to identify the primary diagnosis and divided them to identify if there was change in admission rates with different diagnoses. Standard definition is used for ACS, which includes ST-elevation myocardial infarction (STEMI), non-ST elevation myocardial infarction, and unstable angina. Acute decompensated heart failure (ADHF) included patients with valvular heart disease, cardiomyopathy (ischemic or nonischemic), or arrhythmia presenting with signs of heart failure. Patients were included in the arrhythmia group if they had brady- or tachy-arrhythmia, but without signs of heart failure. Apart from the above definitions and acute pulmonary embolism (PE), all patients admitted to CICU via ER were included in the “Other diagnoses” group (e.g., hypertensive emergencies, metabolic abnormalities, etc.).

Results

During the study period in 2020, a total of 216 patients (age 59 ± 14 years) were admitted via ER, which is a 33% and 30% decline in admissions compared to 2019 (n = 322, age 63 ± 12 years) and 2018 (n = 307, age 62 ± 13 years), respectively. The comparative admissions with the primary diagnosis of ACS, ADHF, arrhythmia, acute PE, and others are shown in Figure 1. The decline in admissions with the primary diagnosis of ACS, ADHF, arrhythmia, and other diagnoses during the study period in 2020 were 27%, 38%, 62%, and 59%, respectively, while there was a 50% increase in acute PE admission compared to the mean admission in 2018 and 2019. On plotting the weekly admission rates during the 15 week period, it was noted that the admission rates gradually increased from less than 10 per week in the first 3 weeks to >15 by eighth week of the study period in 2020, while the trend was same throughout the study period in the previous 2 years (Fig. 2).
Fig. 1

Comparison of cardiac intensive care unit (CICU) admissions with different primary diagnosis during the study period in 2018, 2019, and 2020. ACS, acute coronary syndrome; ADHF, acute decompensated heart failure; PE, pulmonary embolism

Fig. 2

Weekly trend of cardiac intensive care unit (CICU) admissions during the study period in 2018, 2019, and 2020

In those patients who presented with STEMI during the study period in 2020, fibrinolytic therapy (FT) was given to six patients compared to one in 2019 (11.8% vs 1%, p = 0.006). All these six patients had symptoms suspicious of COVID-19 and were admitted during the early part of the study period (first 2 weeks). Emergency coronary angiography rate (88.2% vs 99%, p = 0.006) in STEMI was lower this year, but there was similar rate of primary percutaneous coronary intervention (PPCI) (93.3% vs 89%, p = 0.6) compared to 2020. Comparison of cardiac intensive care unit (CICU) admissions with different primary diagnosis during the study period in 2018, 2019, and 2020. ACS, acute coronary syndrome; ADHF, acute decompensated heart failure; PE, pulmonary embolism The CICU mortality rate in 2020 study period was 4.6% compared to 3.9% in 2018 (p = 0.83) and 5.6% in 2019 (p = 0.70). The in-hospital mortality of these patients was also similar in all 3 years (6.5%, 7.8%, and 7.9% in 2018, 2019, and 2020, respectively, p = 0.61). The COVID-19 reverse-transcription polymerase chain reaction was found to be positive in 15 patients (6.9%) while in CICU, out of which 4 died (26.7%).

Discussion

We believe this is the first report from India addressing the issue of CICU admissions via ER during this pandemic period, even though there were multiple reports about the decline in ACS admissions and catheterization procedures from various countries during this COVID-19 pandemic.[5-14] Our study showed that there was a gradual increase in admissions after the first 3 week period of lockdown. Patients were more reluctant to seek medical attention during the initial pandemic period as there was a panic mode among the public. This was mostly done by both mainstream and social media with information about COVID-19 projected throughout the day. However, as days went by, patients and their relatives were little more confident to come to hospital to get medical attention for non-COVID-19 medical conditions. This could also be partly due to patients not being able to tolerate their symptoms and ended up coming to hospital to seek medical help. Even though our hospital caters for 24/7 PPCI to patients with STEMI, during this lockdown period unusually high number of patients underwent FT (six patients). There are few explanations for this: firstly, during the initial 2 weeks of the study period, interventional cardiologists were reluctant to do PPCI in those patients who had suspicious symptoms of COVID-19 along with history of travel abroad within the prior few weeks. All the six patients who underwent fibrinolysis fulfilled these criteria during the initial triage in emergency department. Therefore, as per the consensus from the cardiac societies, they were given FT in our institute to avoid delay in reperfusion. There were also several concerns about the availability and the quality of personal protective equipment (PPE) during the initial pandemic period. The technique of donning and doffing of PPE by cardiac catheter laboratory staff was also not optimal. Once the staffs were trained with appropriate doffing and donning techniques within the initial 2 weeks, clinicians were able to undertake PPCI even in COVID-19 suspect patients with the necessary precautions, as per the guidelines. There were several hypotheses been postulated to explain the decline in admissions for cardiac emergencies during this pandemic.[15] The main factor is due to the fear of exposure and contracting the virus from an already infected patient in the hospital setup where most COVID-19 patients (symptomatic and asymptomatic) were treated in the initial pandemic period. Apart from these factors discussed earlier, in India, there are other unique factors that would have led to the reduction in emergency cardiac care unit admissions. Nearly half the patients in India with acute medical illness relies on their own transport to reach the hospital in an emergency, as ambulance services are not as par to the western countries. Travelling in their own vehicle during the first few weeks of strict lockdown with frequent vehicle checks being undertaken all over the country must have also contributed to the decline in emergency admissions. Comparatively, even the ambulance services during the initial lockdown period were also much less and would have had a major impact on hospital admissions. Weekly trend of cardiac intensive care unit (CICU) admissions during the study period in 2018, 2019, and 2020

Conclusion

Our study from a large tertiary cardiac unit in South India showed that admissions to CICU was significantly reduced during COVID-19 pandemic. Government and health organizations should educate the public (and also the healthcare professionals who have concerns about seeing and treating patients) early on during the pandemic about the consequences of ignoring other acute medical problems such as ACS, provide various measures for them to reach hospital early and give reassurance with the best practices adopted in hospitals to avoid contracting the virus from the hospital environment.
  13 in total

Review 1.  Management of acute myocardial infarction during the COVID-19 pandemic: A Consensus Statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP).

Authors:  Ehtisham Mahmud; Harold L Dauerman; Frederick G P Welt; John C Messenger; Sunil V Rao; Cindy Grines; Amal Mattu; Ajay J Kirtane; Rajiv Jauhar; Perwaiz Meraj; Ivan C Rokos; John S Rumsfeld; Timothy D Henry
Journal:  Catheter Cardiovasc Interv       Date:  2020-05-13       Impact factor: 2.692

2.  Acute coronary syndrome in the time of the COVID-19 pandemic.

Authors:  Said Ashraf; Suleman Ilyas; M Chadi Alraies
Journal:  Eur Heart J       Date:  2020-06-07       Impact factor: 29.983

3.  The mystery of "missing" visits in an emergency cardiology department, in the era of COVID-19.; a time-series analysis in a tertiary Greek General Hospital.

Authors:  Konstantinos Tsioufis; Christina Chrysohoou; Maria Kariori; Ioannis Leontsinis; Ioannis Dalakouras; Angelos Papanikolaou; Georgios Charalambus; Helen Sambatakou; Gerasimos Siasos; Demosthenes Panagiotakos; Dimitrios Tousoulis
Journal:  Clin Res Cardiol       Date:  2020-06-06       Impact factor: 5.460

4.  Decrease in acute coronary syndrome presentations during the COVID-19 pandemic in upstate New York.

Authors:  Nabil Braiteh; Wajeeh Ur Rehman; Md Alom; Vincent Skovira; Nour Breiteh; Ibraheem Rehman; Alon Yarkoni; Hisham Kahsou; Afzal Rehman
Journal:  Am Heart J       Date:  2020-05-23       Impact factor: 4.749

5.  Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy.

Authors:  Ovidio De Filippo; Fabrizio D'Ascenzo; Filippo Angelini; Pier Paolo Bocchino; Federico Conrotto; Andrea Saglietto; Gioel Gabrio Secco; Gianluca Campo; Guglielmo Gallone; Roberto Verardi; Luca Gaido; Mario Iannaccone; Marcello Galvani; Fabrizio Ugo; Umberto Barbero; Vincenzo Infantino; Luca Olivotti; Marco Mennuni; Sebastiano Gili; Fabio Infusino; Matteo Vercellino; Ottavio Zucchetti; Gianni Casella; Massimo Giammaria; Giacomo Boccuzzi; Paolo Tolomeo; Baldassarre Doronzo; Gaetano Senatore; Walter Grosso Marra; Andrea Rognoni; Daniela Trabattoni; Luca Franchin; Andrea Borin; Francesco Bruno; Alessandro Galluzzo; Alfonso Gambino; Annamaria Nicolino; Alessandra Truffa Giachet; Gennaro Sardella; Francesco Fedele; Silvia Monticone; Antonio Montefusco; Pierluigi Omedè; Mauro Pennone; Giuseppe Patti; Massimo Mancone; Gaetano M De Ferrari
Journal:  N Engl J Med       Date:  2020-04-28       Impact factor: 91.245

6.  Decrease and Delay in Hospitalization for Acute Coronary Syndromes During the 2020 SARS-CoV-2 Pandemic.

Authors:  Gioel Gabrio Secco; Chiara Zocchi; Rosario Parisi; Annalisa Roveta; Francesca Mirabella; Matteo Vercellino; Gianfranco Pistis; Maurizio Reale; Silvia Maggio; Andrea Audo; Daniela Kozel; Giacomo Centini; Antonio Maconi; Carlo Di Mario
Journal:  Can J Cardiol       Date:  2020-05-22       Impact factor: 5.223

Review 7.  Cardiological Society of India: Document on acute MI care during COVID-19.

Authors:  P G Kerkar; N Naik; T Alexander; V K Bahl; R N Chakraborty; S S Chatterjee; H K Chopra; S I Dani; P K Deb; K C Goswami; S Guha; R Gupta; V Gupta; P K Hasija; P B Jayagopal; G Justin Paul; D Kahali; V K Katyal; N N Khanna; M Mandal; S S Mishra; P P Mohanan; A Mullasari; S Mehta; A K Pancholia; S Ray; D Roy; S Shanmugasundarm; S Sharma; B P Singh; S Tewari; S K Tyagi; K N Venugopal; G S Wander; R Yadav; M K Das
Journal:  Indian Heart J       Date:  2020-05-06

8.  Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China.

Authors:  Chor-Cheung Frankie Tam; Kent-Shek Cheung; Simon Lam; Anthony Wong; Arthur Yung; Michael Sze; Yui-Ming Lam; Carmen Chan; Tat-Chi Tsang; Matthew Tsui; Hung-Fat Tse; Chung-Wah Siu
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-03-17

9.  Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic.

Authors:  Santiago Garcia; Mazen S Albaghdadi; Perwaiz M Meraj; Christian Schmidt; Ross Garberich; Farouc A Jaffer; Simon Dixon; Jeffrey J Rade; Mark Tannenbaum; Jenny Chambers; Paul P Huang; Timothy D Henry
Journal:  J Am Coll Cardiol       Date:  2020-04-10       Impact factor: 24.094

10.  Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome.

Authors:  Nicholas S Hendren; Mark H Drazner; Biykem Bozkurt; Leslie T Cooper
Journal:  Circulation       Date:  2020-04-16       Impact factor: 29.690

View more
  3 in total

1.  Non-COVID outcomes associated with the coronavirus disease-2019 (COVID-19) pandemic effects study (COPES): A systematic review and meta-analysis.

Authors:  Vincent Issac Lau; Sumeet Dhanoa; Harleen Cheema; Kimberley Lewis; Patrick Geeraert; David Lu; Benjamin Merrick; Aaron Vander Leek; Meghan Sebastianski; Brittany Kula; Dipayan Chaudhuri; Arnav Agarwal; Daniel J Niven; Kirsten M Fiest; Henry T Stelfox; Danny J Zuege; Oleksa G Rewa; Sean M Bagshaw
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

2.  The impact of COVID-19 on essential health service provision for noncommunicable diseases in the South-East Asia region: A systematic review.

Authors:  Thomas Gadsden; Laura E Downey; Victor Del Rio Vilas; David Peiris; Stephen Jan
Journal:  Lancet Reg Health Southeast Asia       Date:  2022-05-05

3.  Collateral Impact of the COVID-19 Pandemic on Acute Care of Non-COVID Patients: An Internet-based Survey of Critical Care and Emergency Personnel.

Authors:  Swagata Tripathy; Bharath Kt Vijayaraghavan; Manoj K Panigrahi; Asha P Shetty; Rashan Haniffa; Rajesh C Mishra; Abi Beane
Journal:  Indian J Crit Care Med       Date:  2021-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.